You Searched For "Mylan" and got 20 results
Sort By:
1 min read
USFDA accepts proposed biosimilar application by Mylan, Biocon for review
The application seeks approval of Bevacizumab for the first-line and second-line treatment of pati…
PTI
1 min read
Mylan, Biocon launch biosimilar of cancer drug Herceptin in US
New Delhi, Dec 2 () Biotechnology major Biocon and drug firm Mylan NV on Monday announced the launc…
PTI
2 mins read
USFDA pulls up Mylan for manufacturing violations at Andhra plant
New Delhi, Nov 18 () American health regulator USFDA has pulled up Mylan Laboratories for violation…
PTI
1 min read
Biocon, Mylan get USFDA nod for pegfilgrastim drug substance licence
New Delhi, Nov 27 () Biotechnology major Biocon on Wednesday said that US health regulator has appr…
PTI
3 mins read
Mylan is tumbling on reported shortages of its life-saving EpiPens
According to the report, recent actions by US regulators indicate the supply drought could continue…
Daniel Strauss
1 min read
Biocon, Mylan win patent litigation against Sanofi in US for insulin glargine device
"In October 2017, Sanofi had initiated patent infringement litigation against our NDA in the US Di…
PTI
1 min read
Solara Active Pharma to conduct internal probe on Nizatidine API amid Mylan recall
New Delhi, Jan 9 () Amid the voluntary recall of Nizatidine API by Mylan, Solara Active Pharma Scie…
PTI
2 mins read
FDA approves Teva's generic EpiPen in blow to Mylan
"Today's approval of the first generic version of the most-widely prescribed epinephrine auto-injec…
Charlotte Hu,Reuters
2 mins read
$11 billion drugmaker Mylan and US drug giant Pfizer are teaming up to reshape Mylan's business. 3 tough questions from Wall Street analyst show the challenging road ahead.
"This is about enhancing every aspect of our organization, starting with the Board of Directors, st…
Emma Court
2 mins read
Mylan is recalling EpiPens in the US
Mylan was called out in August 2016 for raising the price of the EpiPen to $608.61 from $93.88 over…
Lydia Ramsey
2 mins read
Mylan skyrockets after securing a merger with Pfizer's off-patent drug unit
The new company will be rebranded and renamed, and Heather Bresch - the chief executive officer of …
Daniel Strauss
3 mins read
Investigations are piling up at Mylan
But that's not the only legal matter Mylan's facing. The company's also under investigation generic…
Lydia Ramsey
1 min read
Mylan stock dropped 7% after second quarter sales slumped
Markets Insider
Charlotte Hu
1 min read
Wall Street analysts are throwing shade at Pfizer's deal with Mylan, saying it will hurt profits through 2020
Several Wall Street analysts noted that the company's decision to merge Upjohn - Pfizer's off-paten…
Ben Winck
2 mins read
Mylan, Dr Reddy's, Aurobindo, and Torrent Pharma can't sell generic Gilenya that is patented by Novartis
A US court has ordered generic drug makers including Mylan, Dr Reddy's Laboratories, Aurobindo Ph…
4 mins read
Not everyone is buying into Mylan's EpiPen price plan
"This step seems like a PR fix more than a real remedy, masking an exorbitant and callous price hik…
Lydia Ramsey
1 min read
EpiPen-maker Mylan misses on Q3 earnings
Excluding items, such as the $465 million Department of Justice settlement expense, Mylan said it h…
Lydia Ramsey,Reuters
1 min read
Aurobindo and Intas submit binding offers to buyout Teva UK
Teva is selling its assets after it acquired Allergan Plc's generics business for $40.5-billion in …
3 mins read
Perrigo plunges after Mylan bid flops
Mylan CEO Heather Bresch commented, "Mylan's focused approach to organic and inorganic growth has d…